Sarepta Therapeutics Inc - ESG Rating & Company Profile powered by AI
If you are employed by Sarepta Therapeutics Inc and you wish to licence your ESG aseessment, please contact us. Other corporations in the rating peer group for Sarepta Therapeutics Inc are displayed. The ESG rating covers 17 UN Sustainable Development Goals including: 'Gender Equality', 'Decent Work & Economic Growth' and 'Life on Land'.
Sarepta Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.2; made up of an environmental score of 1.3, social score of 1.1 and governance score of 1.3.
1.2
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1755 | TRACON Pharmaceuticals Inc | 1.3 | Low |
| 1755 | Trimurthi Ltd | 1.3 | Low |
| 1779 | Sarepta Therapeutics Inc | 1.2 | Low |
| 1779 | Cell Biotech Co Ltd | 1.2 | Low |
| 1779 | Aurisco Pharmaceutical Co Ltd | 1.2 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sarepta Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Sarepta Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Sarepta Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Sarepta Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Sarepta Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sarepta Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sarepta Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Sarepta Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Sarepta Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Sarepta Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sarepta Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sarepta Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sarepta Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sarepta Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Sarepta Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Sarepta Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sarepta Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sarepta Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping. The company is also developing AMONDYS 45, a product candidate that uses phosphorodiamidate morpholino oligomer chemistry and exon-skipping technology to skip exon 45 of the dystrophin gene; SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; SRP-9001, a DMD micro-dystrophin gene therapy program; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Lysogene; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.